frontiers 2026
MAY 7, IN NEW YORK CITY
A CELEBRATION AND SHOWCASE OF OUR 2025-26 COHORT
Event Program
MAY 07, 2026 - 8:00 AM to 9:00 PM ET
8:30 am
Checkin & Breakfast
9:00 am
Welcome Address, Investor + Mentor Introductions
10:15 am - 12:15 pm
Morning Presentation Block
Vertical AI Applications; Energy Transition Infrastructure; Oncology Diagnostics & Targeted Therapies; Clinical Workflow & Care Operations; Advanced Materials & Circular Industry; Next-Generation Cell Therapy
11:30 am - 2:15 pm
Lunch
12:20 - 2:20 pm
Afternoon Presentation Block
Agentic Workflow & Predictive Intelligence; Enabling Infrastructure for Autonomy; Immunology & Rare Diseases; Patient Monitoring & Connected Devices
2:30 pm
Fireside Chat with Josh Wolfe, Co-Founder and Managing Partner, Lux Capital Moderated by Deepak Hegde, Founder and Director, Endless Frontier Labs
3:45 - 5:20 pm
Afternoon Presentation Block
AI Trust, Governance, and Infrastructure; Physical AI & Intelligent Robotics; Organ Restoration & Regenerative Medicine; Patient Engagement & Care Navigation; Neurotherapeutics & Brain Health; Intelligent Care Environments
5:30 - 9:00pm
Elizabeth Elting Fund Awards & Reception
GRADUATES
AION Biosystems
AION Biosystems addresses infection in cancer patients by establishing body temperature as a biomarker for early detection with a first-in-class wearable patch & clinical intelligence platform enabling timely intervention & significantly reducing hospitalization & mortality.
Founder(s):
Sam Barend (CEO): MS, Harvard Kennedy School; Tom Blackadar (CTO and COO): BS, University of New Hampshire; Vlad Starzhevsky (CPO): MBA, Harvard Business School
Presentation Block: Patient Monitoring & Connected Devices
Airtrek Robotics
Airtrek Robotics enhances airport ground operations by reducing manual dependency using autonomous robots.
Founder(s):
Chris Lee (CEO): MS, Seoul National University; Huzefa Dossaji (CTO): MS, Clemson University ; Jon Taylor (COO): MS, University of Dayton
Presentation Block: Physical AI & Intelligent Robotics
Akara
Akara helps hospitals reclaim lost operating room time and increase surgical throughput by automating the routine tasks that cause delays using ambient sensing, AI agents, and robotics to eliminate repetitive, manual tasks that disrupt workflow and limit efficiency.
Founder(s):
Conor McGinn (Co-founder and CEO): PhD, Trinity College Dublin; Michael Cullinan (Co-founder and CTO): PhD, Trinity College Dublin; Niamh Donnelly (Co-founder and CTO): MSc, University College Dublin; Eamonn Bourke (Co-founder and COO): MSc, Trinity College Dublin
Presentation Block: Intelligent Care Environments
AlphaChoreo
AlphaChoreo gives enterprises a structured path to deploying AI agents at scale by orchestrating, testing, and governing agentic systems across complex operations.
Founder(s):
Santiago Gomez-Garcia (CEO): MBA, NYU Stern School of Business; Peter Yu (CTO): MS, Zhejiang University; Anthony Han (Chief Strategist): MS, Rice University; Zhihan Zhang (Chief Scientist): PhD, University of Washington"
Presentation Block: Enterprise AI Automation
Alvee Health
Alvee Health helps healthcare organizations operationalize social determinants of health by using autonomous AI care navigation to identify barriers, close care gaps, and convert social risk into measurable clinical action & reimbursable work for value-based care programs.
Founder(s):
Nicole Cook (Founder and CEO): BS, University of Wisconsin-Madison; Rehan Choudhry (Head of AI): PhD, University of Technology and Engineering - Lahore; Courtney Bonewitz (Product Manager): BS, University of Iowa
Presentation Block: Clinical Workflow & Care Operations
AOA Dx
AOA Dx is creating a liquid biopsy test that measures lipid and protein biomarkers and applies machine learning to enable early diagnosis of ovarian cancer.
Founder(s):
Oriana Papin-Zoghbi (Co-founder and CEO): BS, Boston University; Anna Jeter (Co-founder and Chief Regulatory Officer): BS, Boston University; Alex Fisher (Co-founder and Part-time COO): MBA, University of Oxford; Abigail McElhinny (Chief Scientific Officer): PhD, Northeastern University; Chris Roberts (Chief Product Officer): MBA, Duke University
Presentation Block: Oncology Diagnostics & Targeted Therapies
Aperture Bio
Aperture Bio rapidly validates preclinical therapeutic assets using 4D spatial temporal profiling generated by its proprietary organoid and tissue modeling platform.
Founder(s):
Laura Kelley (CEO): MBA, Harvard Business School; Kausar N. Samli (COO): PhD, University of Georgia; Nick Shah (CSO): PhD, University of Toronto
Presentation Block: Oncology Diagnostics & Targeted Therapies
Automated Data
Automated Data uses agentic AI to detect, diagnose, and resolve trading data pipeline issues in real time for financial services firms.
Founder(s):
Michael Rude (CEO): MBA, New York University; Mark Etherington (CTO): MS, University of Kent
Presentation Block: Enterprise AI Automation
Baton Health
Baton Health is transforming healthcare credentialing by centralizing primary source provider data into a real-time data utility & API-driven platform, reducing errors & manual work while enabling systems to onboard clinicians & deliver care with unprecedented speed & scale.
Founder(s):
Robert Coombs (Founder and CEO): MA, University of Colorado; Jahsa Coleman (Chief of Staff): BS, Berkeley City College
Presentation Block: Clinical Workflow & Care Operations
BestDefense
BestDefense continuously simulates adversarial attacks and autonomously hardens enterprise infrastructure using offensive-grade AI.
Founder(s):
Daniel Baddeley (CEO): BS, University of Connecticut; Derek Foster (CTO): BS, Indiana Institute of Technology
Presentation Block: AI Trust, Governance, & Infrastructure
Bioeutectics
Bioeutectis reinvents chemistry with natural, biodegradable solvents using NaDES technology. Its solutions replace petroleum-based solvents, reduce hazardous waste, and enable safer, cleaner industries.
Founder(s):
Tomas Silicaro (CEO): MBA, IAE Busines School; Maria Fernanda Silva (CSO): PhD, Universidad de San Luis; Federico Gomez (CTO): PhD, Universidad de San Luis
Presentation Block: Advanced Materials & Circular Industry
BotBlox
BotBlox enables the data backbone of autonomous systems by designing and manufacturing ultra-compact network and compute hardware and software.
Founder(s):
Josh Elijah (CEO): MEng, University of Manchester; Aaron Elijah (CTO): MS, University of Edinburgh
Presentation Block: Enabling Infrastructure for Autonomy
Carenostics
Carenostics looks to increase transplant volume and improve outcomes by executing transplant workflows using an AI-powered execution layer.
Founder(s):
Kanishka Rao (Co-founder and CEO): BS, University of Pennsylvania - Wharton; Bharat Rao (Co-founder, President, and Chief AI Officer): PhD, University of Illinois Urbana-Champaign; William Landi (CTO): PhD, Rutgers University
Presentation Block: Clinical & Diagnostic Insights
Cell BioEngines
Cell BioEngines is developing off-the-shelf allogeneic cell therapies by chemically reprogramming stem cell fate and function.
Founder(s):
Ajay Vishwakarma (Founder and CEO): Post-doc, Harvard-MIT Health Sciences and Technology and PhD Candidate, Harvard Medical School
Presentation Block: Next-Generation Cell Therapy
CellsBin
CellsBin's ultra-sensitive photonic-AI platform detects and isolates cells as rare as 1 in 10M, enabling single-cell characterization. Initial applications include non-invasive multiple myeloma diagnosis, risk stratification, and post-infusion monitoring of cell therapy.
Founder(s):
Ali Kabiri (CEO): PhD, University of Waterloo; Nima Sarshar (CTO): PhD, McMaster University
Presentation Block: Next-Generation Cell Therapy
Ciba Health
Ciba Health improves outcomes and lowers the total cost of care for complex chronic patients by delivering personalized, root-cause care using an AI-driven platform powered by biomarker testing and continuous biometric data.
Founder(s):
Innocent Clement (Founder and CEO): MD, Columbia University, MBA, Cornell University, MPH, Harvard School of Public Health; Roger Chahine (Founding Team and President): MBA, Cornell University; Markyia Nichols (Founding Team and CMO): MD, University of Maryland; Meethun Panda (Chief Technology and Product Officer): MBA, Cornell University
Presentation Block: Patient Engagement & Care Navigation
Cobionix
Cobionix is building AI-driven robotic systems to automate non-invasive clinical procedures at scale. Its CODI® platform launches with automated ultrasound, addressing workforce shortages, geographic access gaps, and rising demand for diagnostic imaging.
Founder(s):
Matthew Sefati (CEO): BS, University of Waterloo; Dan Vu (Chief of Staff): BBA, Wilfrid Laurier University
Presentation Block: Physical AI & Intelligent Robotics
CogniSea
CogniSea looks to enable real-time autonomous decision-making for physical AI systems by embedding perception and intelligence directly on-sensor using a high-resolution, 3D depth sensing platform.
Founder(s):
Augusto Ximenes (CEO): PhD, Delft University of Technology; Julio Oliveira (COO): PhD, State University of Campinas
Presentation Block: Enabling Infrastructure for Autonomy
Coiled Therapeutics
Coiled Therapeutics is developing next-generation cancer therapies targeting key driver pathways with a first-in-class, orally available small molecule TACC3 inhibitor.
Founder(s):
Sridhar Vempati (CEO): PhD, Ludwig-Maximilians-Universität München; Chaemin Lim (CTO): PhD, Seoul National University; Robbin Frnka (Chief Clinical Officer): BS, Oklahoma State University; Sotirios Stergiopoulos (Chief Medical Advisor): MD, Albert Einstein College of Medicine / Harvard Medical School
Presentation Block: Oncology Diagnostics & Targeted Therapies
Danu Robotics
Danu Robotics is building AI-driven robotic infrastructure for autonomous waste sorting in complex, real-world environments.
Founder(s):
Amy Ma (CEO): MS, University of Edinburgh; Ben Bamford (CTO): BS, Durham University; Ceri Shaw (COO): MEng, University of Cambridge
Presentation Block: Physical AI & Intelligent Robotics
DeepLook Medical
DeepLook Medical is advancing radiology through visual intelligence, providing radiologists one-click measurement and visualization of lesions across all imaging modalities and indications to enhance early detection, diagnostic accuracy, and workflow efficiency.
Founder(s):
Marissa Fayer (CEO): MBA, University of Connecticut; Alice Raia (CTO): MSM, Purdue University; Chirag Parghi (CMO): MD, Baylor College of Medicine; Peter Graham (CCO): BS, Clarkson University
Presentation Block: Clinical & Diagnostic Insights
Elven Technologies
Elven Technologies develops ultra-lightweight, fire-resistant composite materials and battery containment solutions that protect electric vehicles, energy systems, and infrastructure from extreme thermal runaway events.
Founder(s):
Farid Ismayilzada (CEO): MBA, Maastrich School of Management; Vamekh Kherkheulidze (CTO): MD, David Tvildiani Medical University
Presentation Block: Advanced Materials & Circular Industry
Exodys Energy
Exodys Energy is developing UPCYCLE, a small, modular nuclear fuel recycling facility that converts spent fuel into secure and usable domestic feedstock for the current and future reactor fleet.
Founder(s):
Carl Perez (CEO): BS, Babson College; Jean-Christophe Piroux (CTO): MS, Ecole des Mine; Viola Aureggi (CFO): BS, Babson College
Presentation Block: Energy Transition Infrastructure
Extern
Extern gives students and early-career professionals access to structured, mentorship-backed externships that build real credentials with real companies.
Founder(s):
Matt Wilkerson (CEO): BS, MIT; Rodolfo Penna (COO and Head of AI): MBA, Boston University
Presentation Block: Vertical AI Applications
Frontier AI
Frontier AI ingests GTM data in real time to surface actionable guidance across sales conversations and the full revenue cycle.
Founder(s):
Howard Kingston (CEO): MBA, Durham University; Lauren Mckeown (Chief of Staff): BS, Queen's University Belfast
Presentation Block: Enterprise AI Automation
Full Circles Therapeutics
Full Circles Therapeutics is developing a non-viral C4DNA platform to deliver genomic medicines for autoimmune diseases and oncology.
Founder(s):
Howard Wu (CEO and CSO): PhD, Hong Kong University of Science and Technology; Richard Shan (President): PhD, University of Wisconsin - Madison
Presentation Block: Immunology & Rare Diseases
FusionOne
FusionOne reduces emissions and landfill waste by converting end-of-life tires into valuable resources through advanced pyrolysis, AI vision, and proprietary purification technologies.
Founder(s):
Elliott Talbott (CEO): Other, University of Lincoln; John Zorbas (Chair): BS, University of Toronto; Bill O’Banion (Head of Business Growth)
Presentation Block: Advanced Materials & Circular Industry
Genesis Codes
Genesis Codes delivers up to 10x faster data transmission over existing internet infrastructure using a patented Assured-UDP protocol that maximizes throughput and eliminates packet loss, with no hardware changes required.
Founder(s):
Jing Song (Managing Director): MBA, MS, University of Rochester; Lihao Xu (Chief Science Officer): PhD California Institute of Technology; Anthony Mai (Chief Engineer): PhD (unfinished), Penn State University
Presentation Block: Agentic Workflow & Predictive Intelligence
Giftpack
Giftpack automates the entire corporate gifting lifecycle across global markets using AI that personalizes recipient selection, fulfillment, and ROI tracking.
Founder(s):
Archer Chiang (CEO): MA, Academy of Art University; Caroline Sun (General Manager): MS, Dongbei University of Finance and Economics
Presentation Block: Vertical AI Applications
Grinergy
GRiNERGY transforms energy storage with titanate-niobium cells that directly replace lead-acid batteries. They deliver superior safety, durability, and performance, driving faster electrification.
Founder(s):
Scott Bang (CEO): MBA, Aalto University; Byunghoon Chung (COO): PhD, Texas A&M
Presentation Block: Energy Transition Infrastructure
Haply Robotics
Haply advances robotic learning by translating human skill into physical intelligence using intuitive haptic technology.
Founder(s):
Colin Gallache (Co-founder and CEO): MS, McGill University; Steve Ding (Co-founder and Head of Operations): MS, McGill University; Felix Desourdy (Co-founder and Head of Design): B.Eng, École de technologie supérieure
Presentation Block: Physical AI & Intelligent Robotics
ImmuneBridge
ImmuneBridge tackles the cell therapy industry's two biggest manufacturing challenges, scalability and variability, through a single integrated platform.
Founder(s):
Nina Horowitz (CEO): PhD, Stanford University; Rui Tostoes (CTO): PhD, MIT-Portugal Program / IBET
Presentation Block: Next-Generation Cell Therapy
Incepto Medical
Incepto Medical simplifies AI adoption in medical imaging by curating best-in-class AI applications, automating image reporting, and providing dashboards, reducing radiologist reporting time by up to 45% and streamlining AI strategy execution across health systems.
Founder(s):
Antoine Jomier (Co-founder and CEO): MBA, École Nationale des Ponts et Chaussées; Florence Moreau (Co-founder and CTO): MS, CentraleSupélec; Gaspard d’Assignies (Co-founder and CMO): MD, Pierre and Marie Curie University, PhD, Université Paris Cité; Guillaume Bailliard (US President): MBA, Emory University
Presentation Block: Clinical & Diagnostic Insights
Innsightful
Innsightful looks to manage and reduce mental health symptoms such as stress and burnout by using wearable biosignals, AI, and coaching.
Founder(s):
Farzad Ehsani (Co-founder and CEO): MS, Massachusetts Institute of Technology; Demitrios Master (Co-founder and CTO): BS, San Francisco State University; David Pennington (Chief Clinical Officer): PhD, Palo Alto University
Presentation Block: Patient Monitoring & Connected Devices
Lightning Rod Labs
Lightning Rod trains specialized AI prediction models on a company's existing operational data using observed outcomes as the supervision signal, with no labeling or data science teams required.
Founder(s):
Benjamin Turtel (CEO): MS, New York University
Presentation Block: Agentic Workflow & Predictive Intelligence
Linshom Medical
Linshom Medical is the first to deliver a wearable, AI-enabled, FDA cleared, operating room quality respiratory profile to the patient bedside, providing early warning of respiratory problems to avoid costly rapid response activations, rescue events, ICU transfers & deaths.
Founder(s):
Richard Hughen (CEO): MBA, Pennsylvania State University; Ronen Feldman (CTO): BS, University of Maryland
Presentation Block: Patient Monitoring & Connected Devices
Marel Power Solutions
MAREL develops compact light-weight power conversion blocks that simplify electrification across defense, mobility, renewables, and data centers.
Founder(s):
Amrit Vivekanand (CEO): MS, Duke University; Ian Byers (CTO): MS, Wayne State University
Presentation Block: Energy Transition Infrastructure
MegaMinds
MegaMinds prepares learners for the workforce through immersive 3D simulations where AI tutors guide users through real job scenarios.
Founder(s):
Eric Tao (CEO): MFA, Art Center College of Design; Edvard Ãdegaard (CTO): BS, Norwegian University of Science and Technology; Austin Levinson (Director of Learning): MS, Northwestern University
Presentation Block: Vertical AI Applications
Modulight Biotherapeutics
Modulight Biotherapeutics is developing a first-in-class optogenetic precision neuromodulation therapy for neurological disorders, using a patented GPCR-opsin, a light-sensitive protein.
Founder(s):
Yotam Eldar (CEO): MD, Hebrew University; Ofir Levi (Chairman): PhD, Tel Aviv University; Ofer Yizhar (Co-founder and CSO): PhD, Tel Aviv University
Presentation Block: Neurotherapeutics & Brain Health
Muro AI
Muro AI automates scope generation, price benchmarking, and bid leveling for contractors to reduce the time and cost of preconstruction work.
Founder(s):
Kalyan Gautham (Co-founder and CEO): MBA, Cornell University; Stratos Botis (COO): MBA, Cornell University; Gregory Schweickert (Chief AI Officer): MEng, Cornell University
Presentation Block: Enterprise AI Automation
NANOPLUME
NANOPLUME reinvents insulation with scalable Bio-Aerogel, the world’s lightest and thinnest thermal material, making space-age efficiency accessible to mass industries.
Founder(s):
Theresa Hoffmann (CEO): MS, RWTH Aachen University; Tara Love (CTO): PhD, Cambridge University; Tafadzwa Motsi (COO): PhD, University of Birmingham
Presentation Block: Advanced Materials & Circular Industry
NemaGen Discoveries
NemaGen Discoveries is creating therapies for mastocytosis, food allergy, asthma, urticaria, and atopic dermatitis by inhibiting carbonic anhydrase 1 (Car1) in mast cell precursors to safely impair mast cell development.
Founder(s):
Martin Devenport (CEO): PhD, University of Liverpool; Mark Sircusa (President): PhD, Johns Hopkins University
Presentation Block: Immunology & Rare Diseases
Nodal
Nodal is modernizing gestational surrogacy with a tech-enabled platform that connects intended parents and surrogates through trusted, transparent matching, streamlined medical record processing, and real-time support, making family building more accessible and equitable.
Founder(s):
Brian Levine (Co-founder and CEO): MD, New York University; Justin Lynch (VP Engineering): BS, University of Pennsylvania; Taliya Golzar (COO): BS, Duke University; Carly Vollero (General Counsel): JD, Stanford
Presentation Block: Patient Engagement & Care Navigation
Norbert Health
Norbert Health is building an AI module that turns any simple wheeled robot into an autonomous care assistant, automating care management, preventive care programs, and nurse roundings.
Founder(s):
Alexandre Winter (Co-founder and CEO): PhD, Telecom ParisTech
Presentation Block: Intelligent Care Environments
Novus Diagnostics
Novus Diagnostics provides rapid bedside infection diagnostics, identifying and classifying infections in 15 minutes. The platform aims to improve outcomes in serious infections such as sepsis.
Founder(s):
Keith O'Neill (CEO): PhD, National University of Ireland; Kellie Adamson (CSO): PhD, Royal College of Surgeons in Ireland; Elaine Spain (COO): PhD, Dublin City University
Presentation Block: Immunology & Rare Diseases
NX Fuels
NX Fuels is developing a scalable direct solar-to-hydrogen (H₂) platform that produces green hydrogen directly from sunlight and water, without electricity or electrolyzers.
Founder(s):
Saemin Choi (CEO): PhD, The University of Michigan; Zetian MI (CSO): PhD, The University of Michigan
Presentation Block: Energy Transition Infrastructure
OpeniAM
OpenIAM delivers API-first, cloud-native IAM and CIAM governance that gives enterprise IT teams control over access, risk, and compliance at lower cost than legacy identity platforms.
Founder(s):
Ameet Shah (CMO): BS, St. Lawrence University
Presentation Block: AI Trust, Governance, & Infrastructure
Perfusion Medical
Perfusion Medical is developing an IV drug, PM-208, that treats ischemia, saving the lives of critically ill patients.
Founder(s):
Gerard Eldering (Co-founder and CEO): MBA, University of Maryland; Martin Mangino (Co-founder and Inventor): PhD, Michigan State University
Presentation Block: Organ Restoration & Regenerative Medicine
Petra Power
Petra Power is delivering the next 100GW for data centers and the grid by replacing legacy combustion with fast-deployable generation that cuts fuel costs by 90% and eliminates noise, odor, and emissions.
Founder(s):
Aaron Goodman (CEO): PhD, Princeton University; Phillip Clift (CTO): MS, New Mexico Institute of Technology
Presentation Block: Energy Transition Infrastructure
POINT6 BIO
Point6 Bio is developing an AI-powered blood test that analyzes protein biomarker signatures to enable an early, objective, and highly accurate diagnosis of autism.
Founder(s):
Neta Barashi (CEO): PhD, The Hebrew University of Jerusalem; Haitham Amal (CSO): PhD, Technion - Israel Institute of Technology
Presentation Block: Neurotherapeutics & Brain Health
Polygraf AI
Polygraf enforces real-time behavioral control over every AI interaction at the enterprise edge, blocking policy violations, hallucinations, and data exposure before they reach users or regulators.
Founder(s):
Yagub Rahimov (CEO): BA IBMS, Hanze University; Vignesh Karumbaya (COO): MBA, Michigan Ross; Eljan Mahammadli (Head of Provenance): MS, George Washington; Togrul Tahirov (Head of AI Governance): MS, George Washington
Presentation Block: AI Trust, Governance, & Infrastructure
Reactosome
Reactosome is building a redosable gene delivery platform, starting in ocular diseases with limited treatment options.
Founder(s):
Ksenia Burka (CEO): MS, Erasmus University ; Ross McFarland (Tech Lead): PhD, Johns Hopkins University
Presentation Block: Immunology & Rare Diseases
Reditus Space
Reditus Space develops reusable satellites that enable in-orbit manufacturing of pharmaceuticals and semiconductors.
Founder(s):
Stef Crum (CEO): PhD, Georgia Tech; Will Sherman (CTO): MS, Georgia Tech
Presentation Block: Enabling Infrastructure for Autonomy
RedPoint Oncology
RedPoint Oncology is developing a novel payload class for targeted therapies, such as antibody-drug conjugates, to treat therapy-resistant cancers.
Founder(s):
Mengdie (Mandy) Wang (CEO): PhD, University of Arizona
Presentation Block: Oncology Diagnostics & Targeted Therapies
RELAYTO AI
RELAYTO AI converts compliance-approved documents into interactive sales and marketing assets, driving higher engagement and win rates without modifying the underlying approved content.
Founder(s):
Alex Shevelenko (CEO): MBA, Stanford; Pete Vrettakos (Co-founder and COO / GM Insurance): MBA/JD, Yale; Maria Fjod (Global PS and CS Lead): BS, University of Latvia; Nikita Korotaev (Co-founder and CTO): MS, City University of London
Presentation Block: Enterprise AI Automation
RenewalBio
RenewalBio uses a stem cell differentiation platform to address the shortage of transplantable cells and tissues, aiming to restore organ function. It is developing first-in-class cell products and long-term engraftment protocols for clinical use.
Founder(s):
Vladislav Krupalnik (CEO): PhD, Weizmann Institute of Science; Ohad Gafni (CSO): PhD, Weizmann Institute of Science; Jacob Hanna (Chief Scientific Advisor): PhD, Hebrew University of Jerusalem; Omri Amirav Drory (Executive Board Member): PhD, Tel Aviv University
Presentation Block: Organ Restoration & Regenerative Medicine
RevelAi Health
RevelAi Health advances musculoskeletal care by automating patient engagement, documentation, and quality reporting within existing clinical workflows using an AI-powered care orchestration platform, enabling clinicians to deliver more efficient, consistent value-based care.
Founder(s):
Christian Pean (Co-founder and CEO): MD, New York University; Hadi Javeed (Co-founder and CTO): BS, National University of Computer and Emerging Sciences
Presentation Block: Clinical Workflow & Care Operations
Rhino Federated Computing
Rhino Federated Computing enables healthcare, finance, and government organizations to train AI models on sensitive data without sharing it, using federated learning infrastructure that keeps data sovereign.
Founder(s):
Ittai Dayan (CEO): MD, The Hebrew University of Jerusalem; Oran Barkai (VP Financial Services): MBA, The Wharton School
Presentation Block: AI Trust, Governance, & Infrastructure
Sentry AI
Sentry AI replaces manual security monitoring with autonomous AI agents that detect threats and trigger responses in real time, integrating with existing camera and IoT infrastructure.
Founder(s):
Uday Kiran Chaka (CEO): MBA, Duke University; Farhat Ali (COO): MBA, Harvard University
Presentation Block: Vertical AI Applications
SpeedSize
SpeedSize reduces digital media file sizes by up to 99% without visible quality loss using patented psychovisual AI compression, improving load times across web and mobile.
Founder(s):
Sagi Keen (Co-founder and CEO): BA, Sapir College; Vlad Malanin (Co-founder and CTO): MD/PhD, Institute of Cybernetics of NAS of Ukraine
Presentation Block: Agentic Workflow & Predictive Intelligence
Sphaira
Sphaira builds the mobility infrastructure layer for the built world by replacing manual hospital transport staff using a certified robotics platform that gets smarter with every deployment.
Founder(s):
Janis Münch (CEO): MS, HHL Leipzig Graduate School of Management; Chris Ehl (CTO): MS, Technical University of Munich; Rudolf Speth (COO): MS, OTH Amberg-Weiden
Presentation Block: Physical AI & Intelligent Robotics
STAb Tx
STAb Tx aims to deliver durable cancer immunotherapies by enhancing natural T cell engagement while preserving synthetic precision using next-generation STAb-T cells that secrete bispecific T cell engagers.
Founder(s):
Carolina Pola (CEO): PhD, New York University; Luis Alvarez-Vallina (CSO): PhD, Universidad Autonoma de Madrid
Presentation Block: Next-Generation Cell Therapy
Staple
Staple embeds cryptographic provenance and structured context directly into any document filetype so that source, intent, and integrity are machine-verifiable and travel with the file.
Founder(s):
Ben Stein (CEO): Legal Practice & Solicitor, University of Queensland & College of Law; Josh Kettlewell (CTO): PhD, Singapore University of Technology and Design; Hannah Tran (Strategic Accounts Director): National University of Singapore
Presentation Block: AI Trust, Governance, & Infrastructure
Subconscious
Subconscious runs AI-powered causal experiments on behavioral models to identify why customers make decisions, giving businesses insight that surveys and analytics tools cannot provide.
Founder(s):
Avi Yashchin (CEO): MBA, New York University; Subodh Dubey (CSO): PhD, TU Delft
Presentation Block: Agentic Workflow & Predictive Intelligence
Swing Therapeutics
Swing Therapeutics is transforming chronic pain care with the first FDA-cleared digital behavioral therapy, integrating AI-enabled virtual care services, multimodal treatment, and scalable tools to improve access and outcomes, starting with fibromyalgia.
Founder(s):
Mike Rosenbluth (Founder and CEO): PhD, University of California - Berkeley; Nicole Villeneuve (Head of Marketing): BA, Yale University; Eric Hoppe (Head of Software): BS, University of California - San Diego; Dianne Shumay (Head of Psychology): PhD, University of Hawaii
Presentation Block: Patient Engagement & Care Navigation
Tenomix
Tenomix is addressing bottlenecks in cancer pathology by automating manual lymph node detection with a first-in-class AI-powered robotic ultrasound platform, enabling teams to process more cases, reduce costs, and scale across applications, starting with colorectal cancer.
Founder(s):
Saumik Biswas (Co-founder and CEO): PhD, Western University; Mike Lavdas (Co-founder and CTO): MESc, Western University; Eveline Pasman (Co-founder and COO): MD, Radboudumc Health Academy, PhD, University of British Columbia; Sherif Abdou (Co-founder and CBO): PhD, McMaster University
Presentation Block: Intelligent Care Environments
TippingPoint Biosciences
TippingPoint Biosciences has a proprietary drug discovery platform to target high-value epigenetic factors in specific disease contexts. By recapitulating contextual cues and binding partners, it uncovers novel druggable interfaces to enable new therapies.
Founder(s):
Laura Hsieh (CEO): PhD, University of Washington; Geeta Narlikar (Chair of SAB): PhD, Stanford University
Presentation Block: Oncology Diagnostics & Targeted Therapies
Ultrasight
UltraSight transforms cardiac imaging with a first-in-class AI platform that integrates with existing ultrasound systems, enabling any provider to capture diagnostic-quality echocardiograms after a single day of training and deliver critical decisions at the point of care.
Founder(s):
Davidi Vortman (CEO): MBA, Northwestern University; Itay Kezurer (Co-founder and CTO): MS, Weizmann Institute of Science; Ramya Singh (CCO): MBA, Northwestern University
Presentation Block: Clinical & Diagnostic Insights
Verapath (formerly AI Risk)
Verapath provides community banks, credit unions, and asset managers with an AI operating system that enforces firm-defined supervision, risk limits, and regulatory compliance across every AI model and action.
Founder(s):
Alec Crawford (Founder and CEO): BS, Harvard University; Frank Fitzgerald (Co-founder and CTO): BS, Northeastern University; Joe McMann (Co-founder and CRO): MS, Boston University
Presentation Block: AI Trust, Governance, & Infrastructure
VLGE
VLGE generates AI training data by building intelligent 3D environments that capture and package real human interaction as spatial intelligence datasets.
Founder(s):
Evelyn Mora (CEO): BS, University of London
Presentation Block: Vertical AI Applications
Xplorobot
Xplorobot looks to reduce manhours and costs associated with industrial inspections by automating and digitizing inspections workflows using our proprietary hardware and software stack.
Founder(s):
Oleg Mikhailov (CEO): PhD, MIT; Richard Clark (CTO): PhD, Université de Pau et des Pays de l'Adour; Daniel Blattler (President): BS, University of British Columbia
Presentation Block: Physical AI & Intelligent Robotics
Xylo Bio
Xylo Bio is developing therapeutics that enhance neuroplasticity to restore brain function in psychiatric / neurological disorders by unlocking the brain's natural ability to rewire itself. Its small molecule pipeline aims to provide faster, longer-lasting treatment.
Founder(s):
Josh Ismin (CEO): MBA, Washington University; Sam Banister (CSO): PhD, University of Sydney
Presentation Block: Neurotherapeutics & Brain Health
Xylyx Bio
Xylyx Bio is disrupting the organ transplant paradigm by bringing first-in-class human organ grafts to patients to expand the supply of transplantable organs for life-saving clinical transplantation and lower costs for treating end-stage disease.
Founder(s):
Andrea Nye (CEO): MBA, MPH, Columbia University; John O'Neill (CSO): PhD, Columbia University
Presentation Block: Organ Restoration & Regenerative Medicine